A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients
Clinical trial NCT01735968 · COMPLETED
Trial details
- NCT number
- NCT01735968
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-27
- Primary completion
- 2018-10-19
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.